TY - JOUR
T1 - Missing diagnoses of congenital cytomegalovirus infection in electronic health records for infants with laboratory-confirmed infection
AU - Campione, Alexandra
AU - Lanzieri, Tatiana M.
AU - Ricotta, Emily
AU - Grosse, Scott D.
AU - Kadri, Sameer S.
AU - Nussenblatt, Veronique
AU - Prevots, D. Rebecca
N1 - Publisher Copyright:
© 2021 Informa UK Limited, trading as Taylor & Francis Group.
PY - 2022
Y1 - 2022
N2 - Congenital cytomegalovirus (CMV) is a leading cause of non-genetic sensorineural hearing loss and neurodevelopmental disabilities among US children. Studies using administrative healthcare databases have identified infants with congenital CMV using diagnostic codes from the International Classification of Diseases, Ninth and Tenth Revision, Clinical Modification. Using Cerner Health Facts deidentified electronic health records, we assessed the sensitivity of CMV diagnostic codes among infants with laboratory confirmed congenital CMV infection (i.e. a positive CMV laboratory test–polymerase chain reaction, direct fluorescent antibody, or culture from urine, saliva, respiratory secretion or blood samples, or IgM serology–within 21 days of life). During 2010–2017, 668 congenital CMV cases were identified among 7,517,207 infants with encounters within 21 days of life, or 0.89 cases per 10,000 infants. The sensitivity of CMV diagnostic codes assigned within 21 and 90 days of life was 10.3% (95% CI: 8.2–12.9) and 11.1% (95% CI: 8.9–13.7), respectively.
AB - Congenital cytomegalovirus (CMV) is a leading cause of non-genetic sensorineural hearing loss and neurodevelopmental disabilities among US children. Studies using administrative healthcare databases have identified infants with congenital CMV using diagnostic codes from the International Classification of Diseases, Ninth and Tenth Revision, Clinical Modification. Using Cerner Health Facts deidentified electronic health records, we assessed the sensitivity of CMV diagnostic codes among infants with laboratory confirmed congenital CMV infection (i.e. a positive CMV laboratory test–polymerase chain reaction, direct fluorescent antibody, or culture from urine, saliva, respiratory secretion or blood samples, or IgM serology–within 21 days of life). During 2010–2017, 668 congenital CMV cases were identified among 7,517,207 infants with encounters within 21 days of life, or 0.89 cases per 10,000 infants. The sensitivity of CMV diagnostic codes assigned within 21 and 90 days of life was 10.3% (95% CI: 8.2–12.9) and 11.1% (95% CI: 8.9–13.7), respectively.
KW - Congenital cytomegalovirus
KW - diagnostic codes
KW - electronic health records
KW - sensitivity
UR - http://www.scopus.com/inward/record.url?scp=85121294828&partnerID=8YFLogxK
U2 - 10.1080/03007995.2021.2006536
DO - 10.1080/03007995.2021.2006536
M3 - Article
C2 - 34775876
AN - SCOPUS:85121294828
SN - 0300-7995
VL - 38
SP - 273
EP - 275
JO - Current Medical Research and Opinion
JF - Current Medical Research and Opinion
IS - 2
ER -